Image: MedPage TodayCDC Trust Falls Sharply; Watchdog Flags Medicaid Gaps; Drug Targets 'Ozempic Butt'
• A phase II trial published in Nature Medicine found that combining the drug apitegromab with tirzepatide (Zepbound) effectively preserves lean muscle mass, potentially mitigating the muscle loss known as "Ozempic butt." • Massachusetts General Hospital has established a novel vascular clinic specifically designed to provide critical care to homeless individuals to prevent amputations caused by peripheral artery disease. • KFF Health News is exploring the role of overlooked social connections as a potential preventative measure against suicide.
medpagetoday.com







